Nature Reviews Drug Discovery

Nature Reviews Drug Discovery
DisciplinePharmacology, Biotechnology
LanguageEnglish
Edited byPeter Kirkpatrick
Publication details
History2002–present
Publisher
FrequencyMonthly
120.1 (2022)
Standard abbreviations
ISO 4Nat. Rev. Drug Discov.
Indexing
CODENNRDDAG
ISSN1474-1776 (print)
1474-1784 (web)
LCCN2002243044
OCLC no.427380493
Links

Nature Reviews Drug Discovery is a monthly peer-reviewed review journal published by Nature Portfolio. It was established in 2002[1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick.[2] According to the Journal Citation Reports, the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology"[3] and 1st out of 279 journals in the category "Pharmacology & Pharmacy".[4]

Reviews are commissioned to specialists and supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal publishes analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.[5]

  1. ^ "Displaying Record for Publication: Nature Reviews Drug Discovery". CASSI. Chemical Abstracts Service. Retrieved 2022-08-09.
  2. ^ "About the Editors". nature.com. Springer Nature. Retrieved 2022-08-09.
  3. ^ "Journals Ranked by Impact: Biotechnology & Applied Microbiology". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.
  4. ^ "Journals Ranked by Impact: Pharmacology & Pharmacy". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.
  5. ^ Guide : Information : Nature Reviews Drug Discovery. Nature.com. Retrieved on 2011-06-29.